drugset / Trial / NCT01304706

Fluocinolone Acetonide in Diabetic Macular Edema (FAME) Extension Study

NCT01304706

Phase 3 Completed 120 enrolled Alimera Sciences
NaSingle-groupOpen-labelTreatment

Summary

This study will assess the safety and utility of the new inserter for the administration of ILUVIEN in subjects with diabetic macular edema.

Timeline

Start
2011-04
Primary completion
2013-11
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject fluocinolone acetonide Small molecule 0.2 ug